Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients "THROMBONETS"

Withdrawn

Phase N/A Results N/A

Summary of Purpose

Acute Ischemic stroke (AIS) remains a leading cause of adult disability, cognitive impairment and mortality worldwide despite the development of revascularization therapies (intravenous Tissue Plasminogen Activator (t-PA) and endovascular therapy). Thrombosis resistance after IV t-PA therapy is frequent especially in... Trial Stopped: replaced by a new study

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 March 2018.

12 Nov 2015 6 Sep 2016 1 Jul 2017 1 Jul 2017 1 Mar 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

  • Perspective: Cross-Sectional
  • Sampling: Non-Probability Sample

Contacts